Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.
2023; Lippincott Williams & Wilkins; Volume: 210; Issue: 3 Linguagem: Inglês
10.1097/ju.0000000000003598
ISSN1527-3792
AutoresAshesh B. Jani, Gregory Ravizzini, Benjamin A. Gartrell, Barry A. Siegel, Przemyslaw Twardowski, Daniel R. Saltzstein, Mark T. Fleming, Albert Chau, Phillip Davis, Brian F. Chapin, David M. Schuster,
Tópico(s)Radiopharmaceutical Chemistry and Applications
ResumoNo AccessJournal of UrologyLetters to the Editor1 Sep 2023Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.is a reply to letterDiagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Letter. Ashesh B. Jani, Gregory C. Ravizzini, Benjamin A. Gartrell, Barry A. Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T. Fleming, Albert Chau, Phillip Davis, Brian F. Chapin, and David M. Schuster Ashesh B. JaniAshesh B. Jani Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia , Gregory C. RavizziniGregory C. Ravizzini Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas , Benjamin A. GartrellBenjamin A. Gartrell Montefiore Medical Center, Bronx, New York , Barry A. SiegelBarry A. Siegel Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, WashingtonUniversity School of Medicine, St Louis, Missouri , Przemyslaw TwardowskiPrzemyslaw Twardowski Saint John's Cancer Institute, Santa Monica, California , Daniel SaltzsteinDaniel Saltzstein Urology San Antonio, San Antonio, Texas , Mark T. FlemingMark T. Fleming Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia , Albert ChauAlbert Chau Blue Earth Diagnostics Ltd, Oxford, UK , Phillip DavisPhillip Davis Blue Earth Diagnostics, Inc, Monroe Township, New Jersey , Brian F. ChapinBrian F. Chapin Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas , and David M. SchusterDavid M. Schuster Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia View All Author Informationhttps://doi.org/10.1097/JU.0000000000003598AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail REFERENCE 1. . Diagnostic performance and safety of 18F-rhPSMA-7.3 positron emission tomography in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT). J Urol. 2023; 210(2):299-311. Link, Google Scholar Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology22 Jun 2023Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Letter. Volume 210Issue 3September 2023Page: 411-412 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.Metrics Author Information Ashesh B. Jani Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia More articles by this author Gregory C. Ravizzini Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author Benjamin A. Gartrell Montefiore Medical Center, Bronx, New York More articles by this author Barry A. Siegel Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, WashingtonUniversity School of Medicine, St Louis, Missouri More articles by this author Przemyslaw Twardowski Saint John's Cancer Institute, Santa Monica, California More articles by this author Daniel Saltzstein Urology San Antonio, San Antonio, Texas More articles by this author Mark T. Fleming Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia More articles by this author Albert Chau Blue Earth Diagnostics Ltd, Oxford, UK More articles by this author Phillip Davis Blue Earth Diagnostics, Inc, Monroe Township, New Jersey More articles by this author Brian F. Chapin Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas More articles by this author David M. Schuster Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia More articles by this author Expand All Advertisement PDF downloadLoading ...
Referência(s)